New Product Development
The global non-small cell lung cancer market is set to experience remarkable growth in the coming decade. Recent market projections estimate the market value at USD 10 billion in 2023. By 2033, this figure is expected to double, reaching an impressive USD 20 billion. This significant expansion represents a Compound Annual Growth Rate (CAGR) of …
Continue reading “Global Non-Small Cell Lung Cancer Market to Reach USD 20 Billion by 2033”
A recently published study by FMI expects the global Non-Small Cell Lung Cancer Market to augment at a 7.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 20 Billion is expected for the market. From 2018 to 2022, the industry experienced noteworthy growth, registering a value CAGR of …
The global non-small cell lung cancer market had a market value of US$ 10 billion in 2023 and is predicted to reach a market value of US$ 20 billion by 2033, growing at a CAGR of 7.2% from 2023 to 2033. Its rapid expansion can be attributed to an increasing patient population, the projected introduction of many …